Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis.

Marco ScardinoFederica MartorelliTiziana D'AmatoGiorgia FenocchioVincenzo SimiliGuido GrappioloBerardo Di MatteoElizaveta KonMichele Lagioia

Published in: International orthopaedics (2019)

EVICEL® may be effective in reducing red blood cells and plasma transfusion as well as hospital stay. The inclusion of EVICEL® in a blood-saving protocol seems to produce clinical efficacy and cost savings.

Keyphrases

healthcare
red blood cell
patients undergoing
randomized controlled trial
total hip arthroplasty
total knee arthroplasty
cardiac surgery
emergency department
adverse drug